Zacks Investment Research
09 Jul 2026, 16:40 UTC · 2h ago
PAHC or LZAGY: Which Is the Better Value Stock Right Now?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
09 Jul 2026, 16:40 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
Phibro Animal Health (PAHC) currently holds a Zacks Rank of #2 (Buy) and a Value grade of A. — A 'Buy' rank combined with a top value grade suggests a bullish outlook for the specific stock based on earnings revisions and fundamentals.
+0.30Phibro Animal Health (PAHC) has a forward P/E ratio of 9.76 and a PEG ratio of 0.45, compared to Lonza Group Ag's forward P/E of 31.97 and PEG ratio of 1.36. — Lower valuation multiples relative to a peer in the same sector make the stock more attractive to value investors.
+0.20Lonza Group Ag (LZAGY) currently holds a Zacks Rank of #3 (Hold). — A 'Hold' rating indicates a neutral outlook, which typically does not trigger significant price movement.
+0.00Which stocks this story touches
Continue reading
6 related stories
Search tags
The company has a Zacks Rank of #2 (Buy) and a Value grade of A, indicating an improving earnings outlook and undervaluation.
The company is mentioned as a comparison point with a neutral Zacks Rank of #3 (Hold) and less attractive valuation metrics than PAHC.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works

Zacks Investment Research
2h ago